EPS Diluted: 8.75
Is the EPS diluted high or low?
The EPS diluted of 8.75 is in line with its 5-year average of 9.66, near the low end of its 5-year range (7.52–15.53).
6.45% above its 12-month average of 8.22.
DGX EPS Diluted
Reported quarterly diluted EPS; no daily interpolation.
DGX Average EPS Diluted Chart
DGX Current vs Average EPS Diluted Chart
DGX EPS Diluted Metrics
EPS DILUTED
8.75
EPS DILUTED AVG TTM
8.22
EPS DILUTED AVG 3Y
7.99
EPS DILUTED AVG 5Y
9.66
EPS DILUTED AVG 10Y
7.68
EPS DILUTED AVG 15Y
5.91
EPS DILUTED AVG 20Y
5.14
CURRENT VS TTM AVG
+6.45%
CURRENT VS 3Y AVG
+9.58%
CURRENT VS 5Y AVG
-9.47%
CURRENT VS 10Y AVG
+13.97%
CURRENT VS 15Y AVG
+47.97%
CURRENT VS 20Y AVG
+70.10%
EPS Diluted Formula & Definition
EPS Diluted includes the effect of convertible securities, options, and other potential shares. Compare it with basic EPS to see the impact of potential dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EPS Diluted FAQ
- What is the EPS diluted for Quest Diagnostics Incorporated (DGX)?
- The EPS diluted for DGX stock is 8.75.
- Is Quest Diagnostics Incorporated's EPS diluted high or low?
- The EPS diluted of 8.75 is in line with its 5-year average of 9.66, near the low end of its 5-year range (7.52–15.53).
- What is the TTM average EPS diluted for Quest Diagnostics Incorporated (DGX)?
- The TTM average EPS diluted for DGX stock is 8.22.
- What is the 3Y average EPS diluted for Quest Diagnostics Incorporated (DGX)?
- The 3Y average EPS diluted for DGX stock is 7.99.
- What is the 5Y average EPS diluted for Quest Diagnostics Incorporated (DGX)?
- The 5Y average EPS diluted for DGX stock is 9.66.
- What is the 10Y average EPS diluted for Quest Diagnostics Incorporated (DGX)?
- The 10Y average EPS diluted for DGX stock is 7.68.
- What is the 15Y average EPS diluted for Quest Diagnostics Incorporated (DGX)?
- The 15Y average EPS diluted for DGX stock is 5.91.
- What is the 20Y average EPS diluted for Quest Diagnostics Incorporated (DGX)?
- The 20Y average EPS diluted for DGX stock is 5.14.
DGX EPS Diluted History
| DATE | EPS DILUTED |
|---|---|
| 2025-12-31 | 8.75 |
| 2024-12-31 | 7.69 |
| 2023-12-31 | 7.52 |
| 2022-12-31 | 7.98 |
| 2021-12-31 | 15.53 |
| 2020-12-31 | 10.52 |
| 2019-12-31 | 6.29 |
| 2018-12-31 | 5.29 |
| 2017-12-31 | 5.50 |
| 2016-12-31 | 4.51 |
| 2015-12-31 | 4.87 |
| 2014-12-31 | 3.81 |
| 2013-12-31 | 5.54 |
| 2012-12-31 | 3.46 |
| 2011-12-31 | 2.92 |
| 2010-12-31 | 4.05 |
| 2009-12-31 | 3.87 |
| 2008-12-31 | 2.97 |
| 2007-12-31 | 1.74 |
| 2006-12-31 | 2.94 |
| 2005-12-31 | 2.66 |
| 2004-12-31 | 2.35 |
| 2003-12-31 | 2.02 |
| 2002-12-31 | 1.62 |
| 2001-12-31 | 0.83 |
| 2000-12-31 | 0.54 |
| 1999-12-31 | -0.03 |
| 1998-12-31 | 0.22 |
| 1997-12-31 | -0.19 |
| 1996-12-31 | -5.33 |
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis